Related Experiment Video

Updated: May 17, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Tackling hepatitis B virus-associated hepatocellular carcinoma--the future is now

Mausumi Bharadwaj1, Gaurav Roy, Koushik Dutta

  • 1Division of Molecular Genetics & Biochemistry, Institute of Cytology & Preventive Oncology (ICMR), Noida, India. bharadwajm@icmr.org.in

Cancer Metastasis Reviews
|November 2, 2012
PubMed

Insights

Hepatocellular carcinoma (HCC) linked to hepatitis B virus (HBV) infection, particularly the HBx gene, remains a significant health crisis. This review explores current knowledge, challenges, and proposes a new management strategy for HBV-related HCC.

Area of Science:

  • Hepatology
  • Oncology
  • Virology

Background:

  • Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally, especially in developing nations like India.
  • Hepatitis B virus (HBV) infection is a primary etiological factor for HCC, with the HBx gene playing a critical role in its carcinogenicity.
  • Current understanding of the molecular and cellular mechanisms driving HBV-related HCC pathogenesis is limited, and therapeutic options offer minimal clinical benefit.

Purpose of the Study:

  • To review the current state of knowledge on HBV-related HCC.
  • To highlight potential treatment avenues and research strategies for combating this disease.
  • To propose a novel five-point management algorithm for HBV-related HCC.

Main Methods:

  • Comprehensive literature review of HBV-related HCC.
  • Analysis of molecular mechanisms of HBx in HCC.
  • Development of a proposed management algorithm.

Main Results:

  • The review synthesizes current data on HBV-related HCC, emphasizing the critical role of the HBx gene.
  • Identifies significant gaps in understanding disease pathogenesis and therapeutic efficacy.
  • Proposes a novel five-point management algorithm to address unmet needs.

Conclusions:

  • There is an urgent need for novel and effective therapeutic strategies against HBV-related HCC.
  • Further research into molecular mechanisms and environmental factors is crucial.
  • The proposed management algorithm offers a framework for tackling this global health crisis.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...